HUTCHMED (China) Limited (HCM) DCF Valuation
- ✓ Entièrement Modifiable: Adapté À Vos Besoins Dans Excel Ou Sheets
- ✓ Conception Professionnelle: Modèles Fiables Et Conformes Aux Normes Du Secteur
- ✓ Pré-Construits Pour Une Utilisation Rapide Et Efficace
- ✓ Aucune Expertise N'Est Requise; Facile À Suivre
HUTCHMED (China) Limited (HCM) Bundle
Simplify HUTCHMED (China) Limited (HCM) valuation with this customizable DCF Calculator! Featuring real HUTCHMED (China) Limited (HCM) financials and adjustable forecast inputs, you can test scenarios and uncover HUTCHMED (China) Limited (HCM) fair value in minutes.
Discounted Cash Flow (DCF) - (USD MM)
| Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 204.9 | 228.0 | 356.1 | 426.4 | 838.0 | 1,222.9 | 1,784.7 | 2,604.5 | 3,800.9 | 5,546.8 |
| Revenue Growth, % | 0 | 11.27 | 56.21 | 19.73 | 96.52 | 45.93 | 45.93 | 45.93 | 45.93 | 45.93 |
| EBITDA | -135.1 | -182.9 | -208.0 | -401.1 | 25.5 | -723.0 | -1,055.1 | -1,539.7 | -2,247.0 | -3,279.1 |
| EBITDA, % | -65.95 | -80.22 | -58.39 | -94.07 | 3.05 | -59.12 | -59.12 | -59.12 | -59.12 | -59.12 |
| Depreciation | 4.9 | 6.1 | 7.2 | 8.7 | 8.2 | 24.7 | 36.1 | 52.6 | 76.8 | 112.1 |
| Depreciation, % | 2.41 | 2.66 | 2.02 | 2.03 | 0.97936 | 2.02 | 2.02 | 2.02 | 2.02 | 2.02 |
| EBIT | -140.1 | -188.9 | -215.1 | -409.8 | 17.3 | -747.7 | -1,091.1 | -1,592.3 | -2,323.8 | -3,391.2 |
| EBIT, % | -68.37 | -82.88 | -60.41 | -96.1 | 2.07 | -61.14 | -61.14 | -61.14 | -61.14 | -61.14 |
| Total Cash | 217.2 | 435.2 | 1,011.7 | 631.0 | 886.3 | 1,222.9 | 1,784.7 | 2,604.5 | 3,800.9 | 5,546.8 |
| Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
| Account Receivables | 77.2 | 47.9 | 147.7 | 126.7 | 150.5 | 361.5 | 527.6 | 770.0 | 1,123.7 | 1,639.8 |
| Account Receivables, % | 37.67 | 21 | 41.48 | 29.72 | 17.95 | 29.56 | 29.56 | 29.56 | 29.56 | 29.56 |
| Inventories | 16.2 | 19.8 | 35.8 | 56.7 | 50.3 | 112.3 | 163.9 | 239.2 | 349.0 | 509.3 |
| Inventories, % | 7.91 | 8.67 | 10.04 | 13.29 | 6 | 9.18 | 9.18 | 9.18 | 9.18 | 9.18 |
| Accounts Payable | 24.0 | 31.6 | 41.2 | 71.1 | 36.3 | 142.2 | 207.5 | 302.8 | 441.9 | 644.9 |
| Accounts Payable, % | 11.69 | 13.87 | 11.56 | 16.68 | 4.33 | 11.63 | 11.63 | 11.63 | 11.63 | 11.63 |
| Capital Expenditure | -8.6 | -19.6 | -16.8 | -36.7 | -32.6 | -73.3 | -107.0 | -156.1 | -227.8 | -332.4 |
| Capital Expenditure, % | -4.18 | -8.59 | -4.71 | -8.6 | -3.89 | -5.99 | -5.99 | -5.99 | -5.99 | -5.99 |
| Tax Rate, % | -72.84 | -72.84 | -72.84 | -72.84 | -72.84 | -72.84 | -72.84 | -72.84 | -72.84 | -72.84 |
| EBITAT | -143.3 | -193.8 | -227.0 | -409.5 | 29.9 | -747.6 | -1,091.0 | -1,592.1 | -2,323.4 | -3,390.7 |
| Depreciation | ||||||||||
| Changes in Account Receivables | ||||||||||
| Changes in Inventories | ||||||||||
| Changes in Accounts Payable | ||||||||||
| Capital Expenditure | ||||||||||
| UFCF | -216.4 | -173.9 | -342.9 | -407.5 | -46.6 | -963.4 | -1,314.2 | -1,917.9 | -2,798.9 | -4,084.6 |
| WACC, % | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 | 7.85 |
| PV UFCF | ||||||||||
| SUM PV UFCF | -8,419.2 | |||||||||
| Long Term Growth Rate, % | 2.00 | |||||||||
| Free cash flow (T + 1) | -4,166 | |||||||||
| Terminal Value | -71,182 | |||||||||
| Present Terminal Value | -48,776 | |||||||||
| Enterprise Value | -57,196 | |||||||||
| Net Debt | -197 | |||||||||
| Equity Value | -56,998 | |||||||||
| Diluted Shares Outstanding, MM | 174 | |||||||||
| Equity Value Per Share | -327.88 |
What You Will Get
- Editable Forecast Inputs: Effortlessly adjust assumptions (growth %, margins, WACC) to explore various scenarios.
- Real-World Data: HUTCHMED (China) Limited’s financial data pre-loaded to enhance your analysis.
- Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
- Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
- Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and optimizing efficiency.
Key Features
- Comprehensive HCM Data: Pre-loaded with HUTCHMED's historical performance metrics and future outlooks.
- Customizable Financial Assumptions: Tailor revenue growth rates, profit margins, discount rates, tax assumptions, and capital investments.
- Interactive Valuation Framework: Real-time adjustments to Net Present Value (NPV) and intrinsic value reflecting your financial inputs.
- Multiple Scenario Analysis: Develop various forecasting scenarios to evaluate different valuation results.
- Intuitive User Interface: Designed for ease of use, catering to both seasoned professionals and newcomers.
How It Works
- Step 1: Download the Excel file.
- Step 2: Review pre-entered HUTCHMED (China) Limited (HCM) data (historical and projected).
- Step 3: Adjust key assumptions (yellow cells) based on your analysis.
- Step 4: View automatic recalculations for HUTCHMED (China) Limited (HCM)’s intrinsic value.
- Step 5: Use the outputs for investment decisions or reporting.
Why Choose This Calculator for HUTCHMED (China) Limited (HCM)?
- All-in-One Solution: Features DCF, WACC, and financial ratio analyses tailored for HUTCHMED (HCM).
- Flexible Inputs: Modify the highlighted cells to explore different financial scenarios.
- In-Depth Analysis: Automatically computes HUTCHMED's intrinsic value and Net Present Value.
- Preloaded Information: Historical and projected data provide reliable benchmarks.
- Expert-Level Tool: Perfect for financial analysts, investors, and business advisors focusing on HUTCHMED (HCM).
Who Should Use This Product?
- Investors: Accurately assess HUTCHMED (China) Limited’s [HCM] fair value before making investment decisions.
- CFOs: Utilize a professional-grade DCF model for comprehensive financial reporting and analysis of HUTCHMED (China) Limited [HCM].
- Consultants: Easily customize the template for valuation reports tailored to HUTCHMED (China) Limited [HCM] clients.
- Entrepreneurs: Acquire insights into the financial modeling techniques employed by leading pharmaceutical companies like HUTCHMED (China) Limited [HCM].
- Educators: Implement it as a teaching resource to illustrate valuation methodologies relevant to HUTCHMED (China) Limited [HCM].
What the Template Contains
- Pre-Filled DCF Model: HUTCHMED (China) Limited’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate HUTCHMED (China) Limited’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.